Codex DNA announced the release of a mRNA workflow for the BioXp workstation, allowing scientists to generate synthetic mRNA from a DNA sequence in a single overnight run.
The building of mRNA is used for the development of both therapeutics and vaccines, with hundreds of such projects currently in various stages of development. However, the steps required to build mRNA are numerous, time-consuming, and often fraught with difficulties, the company said.
Codex DNA also said its new BioXp small-scale mRNA synthesis kit contains all the Gibson Assembly reagents necessary to make micrograms of biologically active synthetic mRNA using de novo synthesized, error-corrected gene fragments (mRNA template) in a single overnight run.
